Additional acquired resistance mechanisms, mainly identified in BC, involve decreased dependence on estrogen receptor (ER) signaling (due to ER-alpha mutations), ER downregulation, IL6/STAT3 alteration, and DNA damage response pathways in vitro [137, 140]. The gene discussed is ESR1; the disease is breast cancer.